Substance Use Disorders
Letter to the Editor: The Drug Trend Conundrum
Dear Editor: The frequent emergence of new illicit drugs and the ever-evolving trends in their use continue to cause difficulties for clinicians in regard to screening, detection, and treatment and to the different drug monitoring agencies in regard to determining appropriate regulations. Since the advent of synthetic cannabinoids and “bath salts” in recent years, there […]
Quetiapine-induced Bradycardia and Hypotension in the Elderly—A Case Report
by Masaru Nakamura, MD, PhD; Megumi Seki, MD; Yosuke Sato, MD; and Takahiko Nagamine, MD, PhD Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Dr. Seki is with the Department of Internal Medicine, and Dr. Satoh is with the Department of Psychiatry, Kosekai-Kusatsu Hospital, Hiroshima; and Dr. Nagamine is with the Department of […]
Sleep-isolated Trichotillomania (SITTM): A Case Report
by Dharmendra Goyal, MBBS; Sandarsh Surya, MBBS; Joshua Elder, MD; William V. McCall, MD; and Krystle Graham, DO All authors are with the Department of Psychiatry and Health Behavior, Medical College of Georgia, Georgia Regents University in Augusta, Georgia, USA. Innov Clin Neurosci. 2016;13(1–2):40–42. Funding: No funding was received for the preparation of this manuscript. […]
Probable Nootropic-induced Psychiatric Adverse Effects: A Series of Four Cases
by Farid Talih, MD, and Jean Ajaltouni, MD Dr. Talih is an assistant professor and Dr. Ajaltouni is a research fellow at the American University of Beirut Medical Center Department of Psychiatry Innov Clin Neurosci. 2015;12(11–12):21–25. Funding: No funding was received for the preparation of this manuscript. Financial Disclosures: The authors have no conflicts of […]
Letter to the editor: Resident and Patient Responses to the Institution of Required Narcotic Agreements in an Internal Medicine Outpatient Clinic
Dear Editor: An estimated 75 million Americans experience nonmalignant chronic pain,[1] and oftentimes the responsibility for management falls to the primary care provider. Therefore, pain management is an increasingly important clinical skill for residents in primary care fields to master. The use of a narcotic agreement or contract may be one such skill, with reported […]
The Neuroscience Report—Vol. 3 (May 18, 2015): Addiction
The latest in neuroscience—sorted and summarized for you Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. Five Journal Articles […]
Atypical Myopathy: Pentazocine Induced
by Murali K. Kolikonda, MD; Suneela Cherlopalle, MD; Manasa Enja, MD; and Steven Lippmann, MD Drs. Kolikonda, Cherlopalle, Enja, and Lippmann are with the University of Louisville School of Medicine, Department of Psychiatry, Louisville, Kentucky. Innov Clin Neurosci. 2015;12(3–4):24–26.
Buprenorphine Treatment for Narcotic Addiction: Not Without Risks
by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, OH, and Director of Psychiatry Education at Kettering Medical Center in Kettering, OH. L. Sansone is a civilian family medicine physician at the […]
Marijuana and Body Weight
by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, OH, and Director of Psychiatry Education at Kettering Medical Center in Kettering, OH. L. Sansone is a civilian family medicine physician and Medical […]
Letter to the Editor: The Relation Between Body Mass Index and Substance Use: A true Can of Worms
by Adrian Meule, Dipl-Psych From the Institute of Psychology, University of Wurzburg, Wurzburg, Germany Innov Clin Neurosci. 2014;11(3–4):10–13
